Acute kidney injury was associated with a significantly higher risk of in-hospital mortality (OR 5.96) compared to no acute kidney injury in patients undergoing TAVR without chronic kidney disease.
Cohort (n=47,372)
Sí
Does perioperative AKI increase in-hospital mortality and complications in patients undergoing TAVR without CKD?
Perioperative AKI is a strong predictor of in-hospital mortality and complications in patients undergoing TAVR who do not have underlying CKD.
Estimación del efecto: OR 5.96 (95% CI 3.54-10.04)
Tasa de eventos absoluta: 6.21% vs 1.08%
valor p: p=<0.01
BACKGROUND: Acute kidney injury (AKI) complicates transcatheter aortic valve replacement (TAVR), leading to higher mortality. The incidence and effects of AKI on clinical outcomes in patients undergoing TAVR without chronic kidney disease (CKD) are unclear. We aimed to determine the association between AKI and in-hospital outcomes in patients with TAVR using propensity score matching (PSM). METHODS: Using International Classification of Diseases-10th Revision codes, we queried the National Inpatient Sample for TAVR performed between 2016 and 2021. Patients were divided into two groups according to perioperative AKI development. Patients with CKD or on permanent hemodialysis at baseline were excluded. We conducted 1:1 PSM to assemble a cohort of patients with similar baseline characteristics. Multivariate logistic regression was used to assess the association between AKI and in-hospital outcomes. Sensitivity analysis was conducted to evaluate the robustness of our inferences. RESULTS: Of 47,372 unweighted patient admissions for TAVR, 1617 (3.41%) had a concomitant diagnosis of AKI. The incidence of AKI decreased from 4.82 to 3.18% from 2016 to 2021 (P-trend 80 years), sex (male/female), and hypertension status, consistent associations were observed between AKI and the risk of in-hospital mortality. AKI patients were at higher risk for acute myocardial infarction (OR 1.78, 95% CI 1.35-2.34), major bleeding (OR 1.62, 95% CI 1.13-2.33), blood transfusion (OR 1.65, 95% CI 1.28-2.11), and cardiogenic shock (OR 3.73, 95% CI 2.77-5.01). No significant betweengroup differences were observed in stroke (P = 0.12). CONCLUSION: AKI was a strong predictor of in-hospital mortality in patients undergoing TAVR without CKD and was associated with higher post-procedure complication rates.
Ye et al. (Thu,) conducted a cohort in Transcatheter aortic valve replacement (TAVR) without chronic kidney disease (n=47,372). Acute kidney injury (AKI) vs. No acute kidney injury was evaluated on All-cause in-hospital mortality (OR 5.96, 95% CI 3.54-10.04, p=<0.01). Acute kidney injury was associated with a significantly higher risk of in-hospital mortality (OR 5.96) compared to no acute kidney injury in patients undergoing TAVR without chronic kidney disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: